Head-to-head comparisons of medication uses, side effects, warnings, and more.
Amvuttra (vutrisiran) is a prescription injection used to treat nerve damage (polyneuropathy) in adults with a rare condition called hereditary transthyretin-mediated amyloidosis (hATTR). It's also FDA approved to treat heart muscle problems (cardiomyopathy) in adults with either wild-type transthyretin-mediated amyloidosis (ATTRwt) or hATTR. This medication belongs to a drug class called small interfering ribonucleic acids (siRNAs) and is injected under the skin once every 3 months by a healthcare professional. Some common side effects include joint pain and shortness of breath.
Vyndaqel (tafamidis) is a medication taken by mouth used for a rare type of heart disease called transthyretin-mediated amyloidosis cardiomyopathy (ATTR-CM). It's available as two different brand names and is taken once per day.
The following side effects listed in the supplemental appendix of a major clinical study were similar in people taking Vyndaqel (tafamidis) and people taking placebo. Side effects were generally mild to moderate in severity.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.